Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping - Wikidata - wikimedia - TriplyDB

Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping

Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping

http://www.wikidata.org/entity/Q41906651

about

Phenoxybenzamine in complex regional pain syndrome: potential role and novel mechanisms Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data Computational drug repositioning: from data to therapeutics.DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome Microarray analysis of rat sensory ganglia after local inflammation implicates novel cytokines in pain.Systematic evaluation of connectivity map for disease indications Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway Preclinical studies of low back pain.On the Integration of In Silico Drug Design Methods for Drug Repurposing.Drugs that reverse disease transcriptomic signatures are more effective in a mouse model of dyslipidemia.Mining the transcriptome for rare disease therapies: a comparison of the efficiencies of two data mining approaches and a targeted cell-based drug screen.Using the Connectivity Map to discover compounds influencing human osteoblast differentiation.The use of gene arrays and corresponding connectivity mapping (Cmap) to identify novel anti-ageing ingredients.Models of Inflammation: Carrageenan- or Complete Freund's Adjuvant (CFA)-Induced Edema and Hypersensitivity in the Rat.Meta- and cross-species analyses of insulin resistance based on gene expression datasets in human white adipose tissues.Anti-tumor activity of phenoxybenzamine and its inhibition of histone deacetylases.Changing Trends in Computational Drug Repositioning.LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent

P2860

Q27013705-8D655342-B000-4555-865C-6DDA9FA52163 Q28544631-B3DE9B92-EBEB-4A9A-9740-242FA40DB8DF Q30594820-4F5A6FAC-D859-4530-8817-3C024948C69F Q33894409-DAE4803E-18B8-4F85-A74D-1617EC69D227 Q34345165-8EB1856D-84FB-4670-8357-56D798547705 Q34781421-C093CF65-2773-441D-8DFC-6F0FE9EB3922 Q36179224-EF96A10E-34D4-42AE-A113-90D058F0BE7A Q36741799-B4050E4A-4321-4F8D-9E1F-EEFE1C90A33D Q38674008-E5942566-23A1-45F8-B24D-36DFFABA7B95 Q40764658-9397D9A3-512C-4DD0-9084-EF214C7ADBDF Q47143486-A9F6293D-46B9-4839-8295-E4D0199B71DD Q47384641-9220A0B3-D9D8-488E-8B67-67FCEAB7A987 Q51012481-5C6AECD8-8112-4FC9-91A7-1AC0B7445D94 Q53359508-3D92B674-EC11-4E67-8AC8-C481129DF58D Q53706040-961C4DB4-CB3E-41DA-8664-D58ADA513865 Q55227907-7B78013E-5CFA-4E41-8675-BDF8A3D4274E Q55717464-9D87BFFD-8CB9-4969-BC51-99179F795DE6 Q57296199-BB28EFF6-87AA-4DF5-BB98-5C6F5C27F356

P2860

Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping

http://www.wikidata.org/entity/Q41906651

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Evaluation of phenoxybenzamine ...... udies and connectivity mapping

@en

type

label

Evaluation of phenoxybenzamine ...... udies and connectivity mapping

@en

prefLabel

Evaluation of phenoxybenzamine ...... udies and connectivity mapping

@en

P1433

Q41906651-649FB3C4-7B5A-4627-8736-1639C32ADC38

P1476

Q41906651-869E17CA-D84F-4439-9681-3E2DF08A9F21

P2093

Q41906651-34A3DCAF-0168-40CC-B628-229B793A2F35

Q41906651-43616D82-E8F0-437F-BF79-080D8E420E24

Q41906651-866228F1-8318-4CD1-93D0-F7F17B051D63

Q41906651-BFCCF416-6121-4137-BF75-1A108122F4C1

Q41906651-FB7A8DDE-E75D-471B-92AB-65C002BC7D4D

P2860

Q41906651-093B93FD-825C-4BD6-9753-71F4D4BF5ECB

Q41906651-0A130BD3-D162-4225-A310-640428AF7943

Q41906651-0E48D0C1-B556-4BE8-AD54-87DA49D91AF4

Q41906651-1B3B1175-4705-4D96-B6EE-4C23A7206639

Q41906651-23ED0C7F-3B99-4E3D-BE6A-A6A7B79014ED

Q41906651-289EEB3A-02F0-4645-874C-1181FE427727

Q41906651-2AC26E29-327F-4C99-BAAF-769B32414E24

Q41906651-2B41D14C-A555-4436-9292-89D0097A7AF4

Q41906651-2BF8FFB1-7687-4EF9-9982-03047CA4B42C

Q41906651-33D27680-FA39-4B99-B248-137F201FC5D7

P2888

Q41906651-66D06FBC-4BFA-4EAB-9759-518221CDD6A1

P304

Q41906651-23158339-9909-4511-95AC-DF67CD1208BD

P31

Q41906651-D498D35D-F2B3-4D9E-AF29-8AD01EC84B5A

P356

Q41906651-E1C83EA8-93D8-4098-B73D-B01189E81C9D

P478

Q41906651-6DB32304-3908-42CC-8957-9553599BC0F6

P577

Q41906651-241832F6-3715-490C-8C3D-66F44D72F732

P5875

Q41906651-1019062A-0C94-49D2-AE61-F85959737ADE

P6179

Q41906651-4912421F-FFBF-43DC-B5C9-293B16F39230

P698

Q41906651-22AD2B2A-5E0B-4F86-A41D-3935CF1469FD

P932

Q41906651-2099B786-2C70-4C25-9B4B-EECBBC1A48DB

P356

P1433

P1476

Evaluation of phenoxybenzamine ...... udies and connectivity mapping

@en

P2093

Andrew Thorpe

http://www.w3.org/2001/XMLSchema#string

Farzana Karim

http://www.w3.org/2001/XMLSchema#string

Meiping Chang

http://www.w3.org/2001/XMLSchema#string

Michael J Barratt

http://www.w3.org/2001/XMLSchema#string

Sarah Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury

Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain

Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors

Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents

Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation

Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses

CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain

ZHX2 Interacts with Ephrin-B and regulates neural progenitor maintenance in the developing cerebral cortex

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

P2888

P304

56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1744-8069-6-56

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46287610

http://www.w3.org/2001/XMLSchema#string

P6179

1022883983

http://www.w3.org/2001/XMLSchema#string

P698

20846436

http://www.w3.org/2001/XMLSchema#string

P932

2949723

http://www.w3.org/2001/XMLSchema#string